Cetya Therapeutics

A pioneering leader in histone deacetylase inhibitor research, focusing on largazole analogs.

News

Cetya Therapeutics Announces Advanced Industries Award
1 Dec

Cetya Therapeutics Announces Advanced Industries Award

$170,000 Colorado Grant will advance Cetya's novel targeted HDAC inhibitor program (more…)
Cetya Therapeutics Announces STTR Grant Award
22 Sep

Cetya Therapeutics Announces STTR Grant Award

$240,000 Grant will allow evaluation of Cetya's HDAC inhibitors for treatment of sickle cell disease (more…)
Seed Round Financing
8 May

Seed Round Financing

$220,000 Round includes Canadian firm InSynchrony Ventures Inc Proceeds will advance oncology drug development (more…)

About

Collaborations

Research and Development